PharmiWeb.com - Global Pharma News & Resources
08-Jul-2019

Epigenetics Diagnostic Market Size Poised to Touch USD 23.7 Bn by 2026

The Global Epigenetics Diagnostic Market Size is expected to reach USD 23.7 Billion by 2026 and growing CAGR around 20.5 % during the forecast period from 2018 to 2026. Developing predominance of malignant growth and different maladies worldwide with epigenetic change base is required to drive the market amid the conjecture time frame. Also, surge in need for better health related solution and diagonistic service drive the global epigenetic market during the coming years.

Diagnostic organizations are coming up with new products, for example, antibodies explicit for discovery of alterations and new redesigned packs for simple and proficient location of biomarkers. This is evaluated to pull in pharmaceutical organizations to team up for improvement of remedial medications, which will work for the market.

Presence of pipeline drugs and their normal commercialization is foreseen to support the development of the market. For example, Ramucirumab (Cyramza) by Eli Lilly and Company was affirmed by FDA for use in blend with Folfiri for treatment of patients with metastatic colorectal malignancy.

Technology progressions in the epigenetics business are significantly concentrating on identification of methylation markers identified with disease improvement. For example, Epi proLung BL Reflex Assay by Epigenomics helps in finding of lung malignant growth by deciding methylation of SHOX2 biomarker quality.

Rising need to grasp epigenetic changes at sub-nuclear measurement and enhancement of therapeutic courses of action are most likely going to awaken these relationship to fund inventive work programs. In like manner, endeavors, for instance, the Epidemiology and Genomics Research Program (EGRP) grants persuading powers to investigate practices that are advancing toward appreciation of cancer causes and their related outcomes.

Free Download Sample Report Pages For Better Understanding at https://www.acumenresearchandconsulting.com/request-sample/1035

As per NCI, the assessed number of cancer deaths in the U.S. is approximately 163.5 per 100,000 people for each year. The International Cancer Genome Consortium (ICGC) is concentrating on acquiring genomic depiction, epigenomic changes, and transcriptomic changes in various kinds of tumors.

The global epigenetics market is segmented into product, technology, application, and region. On the basis of product, the global epigenetics market is segmented into Bovine, Porcine, Poultry, Marine, and Others. On the basis of product, the global epigenetics market is segmented into reagents, kits, instruments, enzymes, and services. The kits is further bifurcated into chip sequencing kit, whole genomic amplification kit, bisulfite conversion kit, RNA sequencing kit, and others. On the basis of application, the global epigenetics market is segmented into non ndash; oncology and oncology. The oncology segment is further bifurcated into solid tumors and liquid tumors. The non-oncology segment is also bifurcated into inflammatory diseases, metabolic diseases, infectious diseases, cardiovascular diseases, and others. On the basis of technology, the global epigenetics market is segmented into DNA Methylation, Histone Methylation, Histone Acetylation, Large non - coding RNA, MicroRNA modification, and Chromatin structures. On the basis of region the global Epigenetics market is bifurcated into Europe, Latin America, North America, Middle East amp; Africa, and Asia Pacific.

Asia Pacific is evaluated to observe the quickest development over the estimate time frame attributable to rising disposable income, high neglected clinical requirements of patients, rising mindfulness about early finding, and accessibility of successful treatment in rising nations, for example, India and China. Asia Pacific is the most encouraging goal for market players because of expanding instances of different sorts of cancers growths in this region.

North America was at the front line of the market, with an offer of about 41.0% in 2018. Governments in the particular region are empowering continuous research exercises on epigenetics by financing them. Other than this, nearness of cutting edge medicinal services offices and ceaseless headways in analytic methods are animating the development of the provincial market. The market in North America is likewise evaluated to be driven by developing geriatric populace and high acknowledgment for innovatively propelled facilities. Also, typical store upheld programs in the U.S. are relied upon to help epigenetic examine exercises, covering differentiated scope of diseases including oncology and non - oncology illnesses, for example, cardiovascular, metabolic, fiery, and different ailments.

The key players catering to the global epigenetics market are Novartis AG, Roche Diagnostics, Eisai Co. Ltd., and Thermo Fisher Scientific, Inc.

View Full Report at https://www.acumenresearchandconsulting.com/epigenetics-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Epigenetics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Epigenetics Market By Product
1.2.2.1. Global Epigenetics Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Epigenetics Market Revenue Share By Product in 2017
1.2.2.3. Reagents
1.2.2.4. Kits
1.2.2.5. Instruments
1.2.2.6. Enzymes
1.2.2.7. Services
1.2.2.8. Others
1.2.3. Epigenetics Market By Application
1.2.3.1. Global Epigenetics Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Oncology
1.2.3.3. Non - oncology
1.2.3.4. Others
1.2.4. Epigenetics Market By Technology
1.2.4.1. Global Epigenetics Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.4.2. DNA Methylation
1.2.4.3. Histone Methylation
1.2.4.4. Histone Acetylation
1.2.4.5. Large non - coding RNA
1.2.4.6. MicroRNA modification
1.2.4.7. Chromatin structures
1.2.4.8. Others
1.2.5. Epigenetics Market by Geography
1.2.5.1. Global Epigenetics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Epigenetics Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Epigenetics Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Epigenetics Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Epigenetics Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Epigenetics Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Epigenetics Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Epigenetics Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Epigenetics Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Epigenetics Major Manufacturers in 2017

CHAPTER 4. EPIGENETICS MARKET BY PRODUCT

4.1. Global Epigenetics Revenue By Product
4.2. Reagents
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Kits
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Instruments
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Enzymes
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Services
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Other
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. EPIGENETICS MARKET BY APPLICATION

5.1. Global Epigenetics Revenue By Application
5.2. Oncology
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Non - oncology
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. EPIGENETICS MARKET BY TECHNOLOGY

6.1. Global Epigenetics Revenue By Technology
6.2. DNA Methylation
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Histone Methylation
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Histone Acetylation
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Large non - coding RNA
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. MicroRNA modification
6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.7. Chromatin structures
6.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.8. Others
6.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA EPIGENETICS MARKET BY COUNTRY

7.1. North America Epigenetics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Epigenetics Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. U.S.
7.3.1. U.S. Epigenetics Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE EPIGENETICS MARKET BY COUNTRY

8.1. Europe Epigenetics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Epigenetics Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC EPIGENETICS MARKET BY COUNTRY

9.1. Asia-Pacific Epigenetics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Epigenetics Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA EPIGENETICS MARKET BY COUNTRY

10.1. Latin America Epigenetics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Epigenetics Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST EPIGENETICS MARKET BY COUNTRY

11.1. Middle East Epigenetics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Epigenetics Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA EPIGENETICS MARKET BY COUNTRY

12.1. Africa Epigenetics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Epigenetics Market Revenue Share Comparison, 2015 amp; 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Novartis AG
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Roche Diagnostics
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Eisai Co. Ltd.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Thermo Fisher Scientific, Inc.
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Others
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

INQUIRY BEFORE BUYING at https://www.acumenresearchandconsulting.com/inquiry-before-buying/1035

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report at https://www.acumenresearchandconsulting.com/buy-now/0/1035

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 08-Jul-2019